Cormorant Asset Management, LP Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$4.2T
Holdings
104
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (104 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TURNING POINT THERAPEUTICS I | 2,392,297 | $291.5B | 6.94% | |
| 2 | AVIRATEA PHARMACEUTICALS INC | 6,411,355 | $259.8B | 6.18% | |
| 3 | NDQINVESCO QQQ TR | 750,000 | $235.3B | 5.60% | Put |
| 4 | XBISPDR SER TR | 1,500,000 | $211.2B | 5.03% | Put |
| 5 | SPYSPDR S&P 500 ETF TR | 500,000 | $186.9B | 4.45% | Put |
| 6 | BBIOBRIDGEBIO PHARMA INC | 2,265,762 | $161.1B | 3.83% | |
| 7 | —FORMA THERAPEUTICS HLDGS INC | 4,460,000 | $155.7B | 3.70% | |
| 8 | OLMAOLEMA PHARMACEUTICALS INC | 3,195,544 | $148.2B | 3.53% | |
| 9 | APLSAPELLIS PHARMACEUTICALS INC | 1,866,108 | $106.7B | 2.54% | |
| 10 | RVMDREVOLUTION MEDICINES INC | 2,495,066 | $98.8B | 2.35% | |
| 11 | IWMISHARES TR | 500,000 | $98.0B | 2.33% | Put |
| 12 | STOKSTOKE THERAPEUTICS INC | 1,437,807 | $89.0B | 2.12% | |
| 13 | YMABUSDY-MABS THERAPEUTICS INC | 1,661,647 | $82.3B | 1.96% | |
| 14 | CCCCC4 THERAPEUTICS INC | 2,490,065 | $80.0B | 1.90% | |
| 15 | ALXOALX ONCOLOGY HLDGS INC | 881,770 | $76.0B | 1.81% | |
| 16 | BEAMBEAM THERAPEUTICS INC | 924,249 | $75.5B | 1.80% | |
| 17 | BCABBIOATLA INC | 2,292,060 | $75.4B | 1.79% | |
| 18 | RCKTROCKET PHARMACEUTICALS INC | 1,368,550 | $75.1B | 1.79% | |
| 19 | CCXIEURCHEMOCENTRYX INC | 1,200,000 | $74.3B | 1.77% | |
| 20 | IMVTIMMUNOVANT INC | 1,562,952 | $72.2B | 1.72% | |
| 21 | OMEROMEROS CORP | 5,000,000 | $71.4B | 1.70% | Call |
| 22 | MRTXEURMIRATI THERAPEUTICS INC | 325,000 | $71.4B | 1.70% | |
| 23 | TARSTARSUS PHARMACEUTICALS INC | 1,714,269 | $70.0B | 1.66% | |
| 24 | RNAAVIDITY BIOSCIENCES INC | 2,464,547 | $62.9B | 1.50% | |
| 25 | RETAEURREATA PHARMACEUTICALS INC | 500,000 | $61.8B | 1.47% | |
| 26 | PRAXPRAXIS PRECISION MEDICINES I | 1,074,145 | $57.7B | 1.37% | |
| 27 | —ZYMEWORKS INC | 1,200,000 | $56.7B | 1.35% | |
| 28 | XLRNACCELERON PHARMA INC | 425,000 | $54.4B | 1.29% | |
| 29 | 1K0IGM BIOSCIENCES INC | 600,000 | $53.0B | 1.26% | |
| 30 | —VIELA BIO INC | 1,429,200 | $51.4B | 1.22% | |
| 31 | —MYOVANT SCIENCES LTD | 1,700,000 | $47.0B | 1.12% | |
| 32 | —BIOHAVEN PHARMACTL HLDG CO L | 425,000 | $36.4B | 0.87% | |
| 33 | AXNX*AXONICS MODULATION TECHNOLOG | 693,000 | $34.6B | 0.82% | |
| 34 | ALGSALIGOS THERAPEUTICS INC | 1,267,166 | $34.5B | 0.82% | |
| 35 | TWSTTWIST BIOSCIENCE CORP | 225,000 | $31.8B | 0.76% | |
| 36 | SRNESORRENTO THERAPEUTICS INC | 4,500,000 | $30.7B | 0.73% | |
| 37 | CRSPCRISPR THERAPEUTICS AG | 200,000 | $30.6B | 0.73% | |
| 38 | MASS908 DEVICES INC | 545,322 | $29.5B | 0.70% | |
| 39 | GLTOUSDGALECTO INC | 2,150,732 | $26.5B | 0.63% | |
| 40 | ZLABZAI LAB LTD | 189,092 | $25.6B | 0.61% | |
| 41 | 2L9BLUEPRINT MEDICINES CORP | 225,000 | $25.2B | 0.60% | |
| 42 | CABACABALETTA BIO INC | 1,904,424 | $23.8B | 0.57% | |
| 43 | SPRYSILVERBACK THERAPEUTICS INC | 500,000 | $23.2B | 0.55% | |
| 44 | BNTXBIONTECH SE | 275,000 | $22.4B | 0.53% | |
| 45 | AGENEURAGENUS INC | 7,000,000 | $22.3B | 0.53% | |
| 46 | —NOVUS THERAPEUTICS INC | 1,415,500 | $21.4B | 0.51% | |
| 47 | KURAKURA ONCOLOGY INC | 650,000 | $21.2B | 0.51% | |
| 48 | FHTXFOGHORN THERAPEUTICS INC | 1,000,000 | $20.3B | 0.48% | |
| 49 | AKROAKERO THERAPEUTICS INC | 742,549 | $19.2B | 0.46% | |
| 50 | INSPINSPIRE MED SYS INC | 100,000 | $18.8B | 0.45% | |
| 51 | BDQMALBIREO PHARMA INC | 500,000 | $18.8B | 0.45% | |
| 52 | OTICEUROTONOMY INC | 2,600,000 | $16.8B | 0.40% | |
| 53 | ASNDASCENDIS PHARMA A/S | 100,000 | $16.7B | 0.40% | |
| 54 | NTLAINTELLIA THERAPEUTICS INC | 300,000 | $16.3B | 0.39% | Put |
| 55 | AXSMAXSOME THERAPEUTICS INC | 200,000 | $16.3B | 0.39% | |
| 56 | —TCR2 THERAPEUTICS INC | 500,000 | $15.5B | 0.37% | |
| 57 | ANABANAPTYSBIO INC | 650,000 | $14.0B | 0.33% | |
| 58 | PLRXPLIANT THERAPEUTICS INC | 611,409 | $13.9B | 0.33% | |
| 59 | SRPTSAREPTA THERAPEUTICS INC | 70,000 | $11.9B | 0.28% | |
| 60 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 200,000 | $11.4B | 0.27% | |
| 61 | RPTXREPARE THERAPEUTICS INC | 300,000 | $10.3B | 0.24% | |
| 62 | —HEALTH SCIENCES ACQ CORP 2 | 800,000 | $10.2B | 0.24% | |
| 63 | 5E7ITEOS THERAPEUTICS INC | 300,000 | $10.1B | 0.24% | |
| 64 | IM8NINSMED INC | 300,000 | $10.0B | 0.24% | |
| 65 | —AKOUOS INC | 499,990 | $9.9B | 0.24% | |
| 66 | TBPHTHERAVANCE BIOPHARMA INC | 550,000 | $9.8B | 0.23% | |
| 67 | —HARPOON THERAPEUTICS INC | 570,600 | $9.5B | 0.23% | |
| 68 | —BCTG ACQUISITION CORP | 800,000 | $9.2B | 0.22% | |
| 69 | SWTXSPRINGWORKS THERAPEUTICS INC | 125,000 | $9.1B | 0.22% | |
| 70 | QUREUNIQURE NV | 250,000 | $9.0B | 0.21% | |
| 71 | ARGXARGENX SE | 30,000 | $8.8B | 0.21% | |
| 72 | TARAPROTARA THERAPEUTICS INC | 350,000 | $8.5B | 0.20% | |
| 73 | FDMT4D MOLECULAR THERAPEUTICS IN | 200,000 | $8.3B | 0.20% | |
| 74 | GOSSGOSSAMER BIO INC | 848,382 | $8.2B | 0.20% | |
| 75 | —QUOTIENT LTD | 1,500,000 | $7.8B | 0.19% | |
| 76 | ALLKGUSDALLAKOS INC | 50,000 | $7.0B | 0.17% | |
| 77 | —THERAPEUTICS ACQUISITION COR | 500,000 | $7.0B | 0.17% | |
| 78 | MORFMORPHIC HLDG INC | 200,000 | $6.7B | 0.16% | |
| 79 | MRUSMERUS N V | 350,000 | $6.1B | 0.15% | |
| 80 | —GENETRON HLDGS LTD | 400,000 | $5.6B | 0.13% | |
| 81 | —BCLS ACQUISITION CORP | 500,000 | $5.5B | 0.13% | |
| 82 | —FS DEV CORP | 500,000 | $5.5B | 0.13% | |
| 83 | —5 01 ACQUISITION CORP | 500,000 | $5.1B | 0.12% | |
| 84 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 400,000 | $4.9B | 0.12% | |
| 85 | —VESPER HEALTHCARE ACQSTN COR | 400,000 | $4.8B | 0.12% | |
| 86 | REPLREPLIMUNE GROUP INC | 125,000 | $4.8B | 0.11% | |
| 87 | MLTXHELIX ACQUISITION CORP | 430,000 | $4.7B | 0.11% | |
| 88 | BCELATRECA INC | 293,500 | $4.7B | 0.11% | |
| 89 | AUTLAUTOLUS THERAPEUTICS PLC | 422,167 | $3.8B | 0.09% | |
| 90 | —KADMON HLDGS INC | 850,000 | $3.5B | 0.08% | |
| 91 | —AVROBIO INC | 244,032 | $3.4B | 0.08% | |
| 92 | —PANACEA ACQUISITION CORP | 250,000 | $3.2B | 0.08% | |
| 93 | 1T7TRICIDA INC | 427,975 | $3.0B | 0.07% | |
| 94 | DTILPRECISION BIOSCIENCES INC | 346,524 | $2.9B | 0.07% | |
| 95 | CRDFCARDIFF ONCOLOGY INC | 150,000 | $2.7B | 0.06% | |
| 96 | ARNAEURARENA PHARMACEUTICALS INC | 20,000 | $1.5B | 0.04% | |
| 97 | —MIRAGEN THERAPEUTICS INC | 93,126 | $1.5B | 0.04% | |
| 98 | ORTXUSDORCHARD THERAPEUTICS PLC | 256,649 | $1.1B | 0.03% | |
| 99 | FATEFATE THERAPEUTICS INC | 10,000 | $909.0M | 0.02% | |
| 100 | —CEREVEL THERAPEUTICS HLDNG I | 133,331 | $753.0M | 0.02% |
Page 1 of 2Next